Skip to content

Per-oral Pyloromyotomy for Treating Infantile Hypertrophic Pyloric Stenosis

Per-oral Pyloromyotomy for Treating Infantile Hypertrophic Pyloric Stenosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04148040
Enrollment
20
Registered
2019-11-01
Start date
2019-01-01
Completion date
2020-12-31
Last updated
2019-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hypertrophic Pyloric Stenosis, Pyloromyotomy

Brief summary

Infantile hypertrophic pyloric stenosis (IHPS) is the most common condition for surgical treatment in infant. Traditionally, laparoscopic or open pyloromyotomy are the standard treatments. However, because of severe dehydration, electrolyte disturbance, and malnutrition, these patients have lower tolerance about surgery and recover more slowly than usual. We are going to study the per-oral pyloromyotomy (POP), also named as gastric per-oral endoscopic myotomy (G-POEM), which showed promising results for adult gastroparesis, for a novel application of treating IHPS.

Interventions

PROCEDUREG-POEM

Per-oral pyloromyotomy (POP), also named as gastric per-oral endoscopic myotomy (G-POEM), for treating infantile hypertrophic pyloric stenosis (IHPS) has the following steps: mucosal incision, creation of submucosal tunnel, full-thickness pyloromyotomy, closure of the mucosal entry.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of pyloric stenosis with or without sonographic confirmation.

Exclusion criteria

* Comorbid conditions that could affect postoperative recovery. * Needed an additional procedure during the same anaesthetic.

Design outcomes

Primary

MeasureTime frameDescription
episodes of postoperative vomiting6 months after surgeryPrimary outcomes included episodes of postoperative vomiting in times.
major complication6 months after surgeryPrimary outcomes included major complication in times (based on lexicon and Clavien-Dindo classification, eg, vital-sign instability, ICU stay, hospital readmission, conversion to laparoscopic or open pyloromyotomy, invasive postoperative procedure, haemorrhage, blood transfusion, or prolonged hospitalization due to functional impairment).

Secondary

MeasureTime frameDescription
other complications6 months after surgerySecondary outcomes included other complications (yes or no) (eg, mucosal injury, delayed mucosal barrier failure, incomplete pyloromyotomy, and respiratory complications without invasive intervention).
postoperative pain assessment by Pain assessment for children under four years6 months after surgerySecondary outcomes included postoperative pain assessment in score. This measurement chart is Pain assessment for children under four years which of pain scoring in the postoperative set up is: Cry (yes or no), Posture (relaxed or tense), Expression (relaxed, happy or distressed), Response when spoken to (yes or no). (Gupta A, Kaur K, Sharma S, Goyal S, Arora S, Murthy RS. Clinical aspects of acute post-operative pain management & its assessment. J Adv Pharm Technol Res. 2010;1(2):97-108.)
analgesia requirements6 months after surgerySecondary outcomes included analgesia requirements (yes or no).
operating and anaesthetic time6 months after surgerySecondary outcomes included operating and anaesthetic time in minutes.
postoperative length of stay6 months after surgerySecondary outcomes included postoperative length of stay in days.
need for re-operation6 months after surgerySecondary outcomes included need for re-operation (yes or no).
time to full enteral feed6 months after surgerySecondary outcomes included time to full enteral feed in hours.
myotomy length6 months after surgerySecondary outcomes included myotomy length in centimeters

Countries

China

Contacts

Primary ContactQuanlin Li
li.quanlin@zs-hospital.sh.cn64041990
Backup ContactZuqiang Liu
16111210047@fudan.edu.cn64041990

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026